MTHFD2:一个重要的线粒体代谢酶,也是抗癌疗法的新目标
Shuyu Liu1, Xiaoke Wang2, Liye Zhao1
1Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University, Baoding, Hebei 071002, China.
Drug discovery today
|May 10, 2025
概括
甲基基酸脱酶2 (MTHFD2) 是一种在瘤中过度表达的关键酶,驱动癌症的进展. 这篇评论探讨了MTHFD2的情况.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 代谢途径 代谢途径
背景情况:
- MTHFD2是叶酸单碳代谢中的线粒体酶.
- 在各种瘤中,MTHFD2的升高调节,与预后不佳相关.
- MTHFD2在瘤中过度表达,但在正常组织中没有,这使得它成为潜在的癌症标.
研究的目的:
- 审查MTHFD2在癌症中的功能.
- 讨论MTHFD2的监管机制.
- 总结关于MTHFD2抑制剂和未来方向的研究.
主要方法:
- 在癌症中对MTHFD2功能,调节和抑制剂的文献综述.
- 对瘤与正常组织中的MTHFD2表达模式的分析.
- 对MTHFD2向治疗的当前研究的综合.
主要成果:
- MTHFD2在瘤发育和进展中起着重要作用.
- 在癌症中确定了MTHFD2的特定调节机制.
- 目前正在研究各种MTHFD2抑制剂.
结论:
- MTHFD2是抗癌药物开发的有前途的治疗标.
- 为了设计有效的MTHFD2抑制剂,需要进一步的研究.
- 准MTHFD2为癌症治疗提供了一个新的策略.
相关概念视频
Electron Transport Chain: Complex I and II
12.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.4K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


